DIRS.INFO top alerts submit data jurnalism about API
login
Top related persons:
CNBC's Jim Cramer - 1 Eli Lilly - 1 Jensen Huang - 1 Cramer - 1 it's - 1 he'll - 1 Seagen - 1 there's - 1
Top related locs:
It's China Wingstop Carvana Britain Delaware Delta FactSet
Top related orgs:
Walgreens - 3 Pfizer - 2 Apple - 1 Federal Reserve - 1 Department of Labor - 1 Nvidia - 1 Food and Drug Administration - 1 Starbucks - 1

Search resuls for: "Walgreens ."


5 mentions found


☆ Cramer's week ahead: Fed meeting and earnings from Apple, Amazon, Eli Lilly
  + stars: | 2024-04-26 | by ( Julie Coleman | ) www.cnbc.com   time to read: +2 min
It's a week jam-packed with notable events, including earnings from Apple , Amazon and Eli Lilly . He also said to pay attention to Wednesday's Federal Reserve meeting and Friday's employment figures from the Department of Labor. "We have to run such a ridiculous gauntlet next week that I have no idea how it'll play out," he said. Wednesday also brings reports from Wingstop , Carvana and Marriott . Apple will report on Thursday, and Cramer noted there's been a lot of negative sentiment from investors surrounding the company.
Persons: CNBC's Jim Cramer, Eli Lilly, Jensen Huang, Cramer, it's, he'll, Seagen, there's Organizations: Apple, Federal Reserve, Department of Labor, Nvidia, Food and Drug Administration, Starbucks, CVS, Pfizer, Amazon, Walgreens, Marriott, Vision Locations: It's, China, Wingstop, Carvana
☆ GSK sues Pfizer in U.S. court for patent infringement over RSV vaccine
  + stars: | 2023-08-02 | by ( Annika Kim Constantino | ) www.cnbc.com   time to read: +1 min
GlaxoSmithKline on Wednesday sued Pfizer in U.S. court, alleging patent infringement over Britain-based GSK's respiratory syncytial virus vaccine. GSK claims Pfizer's RSV vaccine, Abrysvo, infringes on four of its patents related to the antigen used in its own shot. "Upon information and belief, Pfizer knowingly uses GSK's claimed inventions in Abrysvo without permission," GSK wrote in a scathing complaint filed in federal court in Delaware. They are the first shots approved to prevent RSV, a common respiratory infection that usually causes mild, cold-like symptoms, but more severe cases in older adults and children. Each year, RSV kills 6,000 to 10,000 seniors and a few hundred children younger than 5, according to CDC data.
Persons: infringes Organizations: GlaxoSmithKline, Wednesday, Pfizer, GSK, U.S . Food, Drug Administration, Walgreens Locations: Britain, Delaware
☆ Take-Two, this drug name are among the most overbought stocks on Wall Street. Here are the others
  + stars: | 2023-07-03 | by ( Alex Harring | ) www.cnbc.com   time to read: +3 min
Investors were snapping up shares of stocks including AmerisourceBergen and Take-Two in the last two weeks of the second quarter. CNBC Pro compiled the other most overbought stocks below: Airline stocks Southwest and Delta made the list, with both having an index above 90. Wall Street has a favorite among the two competitors: nearly 86% of analysts rate Delta a buy compared with nearly 43% for Southwest. But Wall Street does expect the 2023 rally to continue, with the average price target implying a nearly 7% upside from here. But the average Wall Street analyst expects shares to rally more than 25% in the next year.
Persons: AmerisourceBergen, Mills, General Mills, Zions Bancorporation, Fred Imbert Organizations: Walgreens, Nasdaq, CNBC Pro, Delta, Southwest Locations: Delta, FactSet
☆ Rallies from Walgreens, PVH and McCormick could be a good sign for earnings season, Cramer says
  + stars: | 2023-03-28 | by ( Ashley Capoot | ) www.cnbc.com   time to read: +1 min
Stocks that rallied Tuesday in response to "less than stellar" quarterly reports could bode well for earnings season, CNBC's Jim Cramer said. Cramer pointed to three companies that reported within the last 24 hours as examples: Spice company McCormick , Calvin Klein and Tommy Hilfiger parent company PVH and Walgreens . The company reported earnings growth of 10%, above the 8.9% consensus number. Walgreens' rally was also "totally baffling," Cramer said, because it reported an adjusted operating income of $1.2 billion that missed consensus estimates. Cramer said he thinks these companies are representative of the broader market.
☆ Here are Goldman’s top stock picks to play a rising interest rate world
  + stars: | 2023-03-09 | by ( Yun Li | ) www.cnbc.com   time to read: +1 min
Equity duration is the time until the company's cash flows are received, weighted by their present values. Goldman defines its equity duration estimates as a weighted-average distribution of cash flows. However, short-duration stocks are the ones with strong earnings today, but no promise of earnings growth down the road. These short-duration names may provide a hedge against rising rates. The median implied equity duration for stocks in the basket is 18.3 years versus 22.2 years for the Russell 1000.
0 next >>
Total: 5